Publicacións en colaboración con investigadores/as de University of Münster (29)

2023

  1. Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists

    Communications biology, Vol. 6, Núm. 1, pp. 376

2022

  1. Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1361-1368

2021

  1. Breast cancer risk genes - Association analysis in more than 113,000 women

    New England Journal of Medicine, Vol. 384, Núm. 5, pp. 428-439

  2. The pi3kδ inhibitor idelalisib diminishes platelet function and shows antithrombotic potential

    International Journal of Molecular Sciences, Vol. 22, Núm. 7

2017

  1. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

    Nature Genetics, Vol. 49, Núm. 12, pp. 1767-1778

  2. NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 46, pp. 12315-12320

2014

  1. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 87, Núm. 1, pp. 47-54